Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study
Human Psychopharmacology: Clinical and Experimental · 2025
DOI: 10.1002/hup.70006 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2025. Verfasst von Jing Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Mental Health Center, Xi'an, China. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents, Schizophrenia. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Research Fund Project of Xi'an Health Commission.
Abstract (Originalsprache)
Background
Due to its short plasma half‐life, clozapine is typically prescribed in a divided dosing regimen. Although once‐daily dosing has proven effective in countries such as Japan, South Korea, Canada, and the United States, its adoption in real‐world clinical practice in China remains unclear. This study aimed to compare patient characteristics, psychiatric symptoms, side effects, and plasma clozapine concentrations between once‐daily and divided dosing regimens, and to determine the dosage required to achieve plasma levels of 350–600 ng/mL in the Chinese population.
Methods
We conducted a single‐center, retrospective, cross‐sectional study at Xi'an Mental Health Center, China, collecting data on clozapine‐treated patients from March 2019 to March 2021.
Results
Most patients (80% of 198) in the Chinese cohort followed a divided‐dose regimen in clinical practice. In the once‐daily dosing group, the average plasma clozapine concentration was 158.75 ng/mL, with only 8% of patients reaching the therapeutic window. Conversely, patients on a divided dosing regimen had significantly higher plasma concentrations, averaging 373.34 ng/mL, with 28% within the therapeutic window. The psychiatric symptom remission rate did not differ significantly between the once‐daily and divided‐dosing groups (50.05% vs. 52.72%, p = 0.718); however, the divided‐dosing group experienced a greater variety of adverse effects. Receiver operating characteristic analysis indicated that patients on multiple daily doses require a total daily clozapine dose of 150–250 mg to achieve the target plasma concentration, corresponding to a clozapine concentration‐to‐dose ratio of 1.4–2.4.
Conclusions
Chinese clinicians generally adhere to a divided dosing schedule for clozapine when the daily dose exceeds 50 mg. Further prospective longitudinal studies are warranted to evaluate whether once‐daily dosing regimens can improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xi'an Mental Health Center, Xi'an, China.
ORCID-Profile: Jing Ding
Förderung
- Research Fund Project of Xi'an Health Commission
Zitieren
APA
Ding, J., Zhang, S., Xing, H., & Li, L. (2025). Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.70006
Vancouver
Ding J, Zhang S, Xing H, Li L. Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study. Human Psychopharmacology: Clinical and Experimental. 2025. doi:10.1002/hup.70006
BibTeX
@article{Ding2025,
author = {Ding, Jing and Zhang, Suo and Xing, Huan and Li, Luyao},
title = {Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2025},
doi = {10.1002/hup.70006}
}
EUVIMED